FDA Inspection 744408 — Rhode Island Blood Center, A Division of New York Blood Center, Inc.

Rhode Island Blood Center, A Division of New York Blood Center, Inc. — FEI 1270007

The FDA completed an inspection of Rhode Island Blood Center, A Division of New York Blood Center, Inc. on September 8, 2011 in Providence, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 8, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Providence, RI (United States)